![Raul Collazo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Raul Collazo
Director Técnico/Científico/I+D en CONNECT BIOPHARMA HOLDINGS LIMITED .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Wubin Pan | M | 60 | 12 años | |
Zheng Wei | M | 61 | 9 años | |
Kleanthis Xanthopoulos | M | 66 | 4 años | |
Catherine Schnabel | M | - |
Biotheranostics, Inc.
![]() Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | 15 años |
Jiang Bian | F | - | 3 años | |
Kan Chen | M | 42 | 4 años | |
Karen Wilson | F | 61 | 4 años | |
Jean Liu | F | 55 | 3 años | |
Matt Sargent | M | - |
Biotheranostics, Inc.
![]() Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | 11 años |
Alejandro Sanchez | M | - |
Biotheranostics, Inc.
![]() Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | - |
Marci Lerner | F | 60 |
Biotheranostics, Inc.
![]() Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | - |
David Kabakoff | M | 76 |
Biotheranostics, Inc.
![]() Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | - |
Steven Chan | M | 52 | 3 años | |
Zuie Chin Huang | M | 58 | - | |
Eric Bednarski | M | 52 |
Biotheranostics, Inc.
![]() Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | - |
Gail A. Sloan | F | 61 |
Biotheranostics, Inc.
![]() Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | 11 años |
Lei Sun | M | 60 | 4 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Malinda V. Longphre | M | - | 3 años | |
Eric J. Hall | M | 69 | 1 años | |
Chin Lee | M | 54 | - |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 20 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Raul Collazo
- Red Personal